MARIA SMIT: Open Payments
NPI 1821309733 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,333 in 106 payments from 19 companies in 2025. Trend: 2023 $3,203 · 2024 $1,822 · 2025 $3,333
Food & beverage: $2,101Consulting: $1,125Education: $107
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $1,543 |
| UCB, Inc. | 23 | $263 |
| ABBVIE INC. | 11 | $234 |
| Amgen Inc. | 6 | $157 |
| GENZYME CORPORATION | 7 | $157 |
| Novartis Pharmaceuticals Corporation | 6 | $152 |
| PFIZER INC. | 7 | $138 |
| Galderma Laboratories, L.P. | 7 | $132 |
| Lilly USA, LLC | 3 | $122 |
| LEO Pharma Inc. | 5 | $103 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, OTEZLA, EBGLYSS, CIBINQO, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
